Monday, April 13, 2015

Sangamo Named one of Jefferies top ten buyout targets

Buyout Targets

Jefferies recommends buying the following 10 potential M&A targets:
1. Arena Pharmaceuticals, Inc. ARNA 0.22%
2. Lexicon Pharmaceuticals, Inc. LXRX 0.56%
3. Seattle Genetics, Inc. SGEN 2.18%
4. Sangamo Biosciences, Inc. SGMO 0.97%
5. DHT Holdings Inc DHT 2.02%
6. BioScrip Inc BIOS 2.96%
7. OraSure Technologies, Inc. OSUR 0.15%
8. Sonus Networks, Inc. SONS 0.26%
9. NuVasive, Inc. NUVA 1.12%
10. Allscripts Healthcare Solutions Inc MDRX 0.65%


No comments:

Post a Comment